| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |